Genotyping Market Size, Share, Growth, Forecast by 2028

Genotyping Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product and Service (Instruments, Reagents and Kits, Bioinformatics, and Genotyping Services), Technology (Microarrays, Capillary Electrophoresis, Sequencing, Polymerase Chain Reaction (PCR), Matrix-Assisted Laser Desorption/Ionization-Time of Flight (Maldi-Tof) Mass Spectrometry, and Others), Application (Pharmacogenomics, Diagnostics and Personalized Medicine, Animal Genetics, Agricultural Biotechnology, and Others), End-User (Pharmaceutical and Biopharmaceutical Companies, Diagnostic and Research Laboratories, Academic Institutes, and Other), and Geography

Publication Month : Jun 2022

  • Report Code : TIPHE100001166
  • Category : Pharmaceuticals
  • Status : Published
  • No. of Pages : 240
Inquire Before Buy

PRICING

$4550

$3640

The genotyping market is expected to grow from US$ 79,407.14 million in 2028 from US$ 25,191.28 million in 2022; it is estimated to grow at a CAGR of 20.1% during 2022–2028.

Genotyping is a process of studying the individual’s DNA sequence, and one can analyze the genetic differences through biological assays and for comparison with other individuals’ progression. Genotyping can help researchers study genetic deviations such as single nucleotide polymorphisms and significant structural changes in DNA. Human genotyping helps determine motherhood or fatherhood; Genotyping of micro-organisms, including bacteria and viruses.

The genotyping market is segmented into product and service, technology, application, end user, and geography. By geography, the market is broadly segmented into North America, Europe, Asia Pacific, the Middle East & Africa, and South & Central America. This report offers insights and in-depth analysis of the market, emphasizing parameters, such as market trends, market dynamics, and the competitive analysis of the globally leading market players. 


Customize Research To Suit Your Requirement

We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.

Genotyping Market: Strategic Insights

genotyping-market
Market Size Value inUS$ 25,191.28 million in 2022
Market Size Value byUS$ 79,407.14 million by 2028
Growth rateCAGR of 20.1% from 2022 to 2028.
Forecast Period2022-2028
Base Year2022
Analyst Image

Akshay

Have a question?

Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

Analyst Image  Speak to Analyst



Lucrative Regions for Genotyping Market

  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
  • Request discounts available for Start-Ups & Universities

Market Insights

Use of Genotyping in Drug Development for Genetic and Rare Diseases along with Technological Advancements and Rising R&D Investments in Pharmaceutical and Biotechnology to Drive Genotyping market

The players operating in the genotyping industry are focusing on increasing their investments in developing advanced biotechnological technologies as they offer a better alternative to conventional techniques. As these tests provide superior accuracy in disease diagnosis, the companies are looking forward to investing considerable money in product development. Additionally, growing research and development activities such as government funding for genome-based projects also contribute to the overall growth of the genotyping market. For instance, in September 2019, the UK government partnered with pharmaceutical firms and health experts and created a £200 million (USD 245.68 million) whole-genome sequencing project to examine and sequence the genetic code of 500,000 volunteers in the UK Biobank, based in Stockport. Such investments and developments in the genotyping market create significant growth opportunities for the market players.

A few examples of companies that have participated in developments are listed below:

  • In May 2022, NEOGEN Corporation and Gencove announced the launch of InfiniSEEK, an innovative and cost-effective solution for solving Whole-genome sequencing and targeted SNP analysis.
  • In July 2020, the enhanced version of the BD Onclarity HPV assay was FDA approved for premarket supplements and was the only assay currently approved to individually identify and report the genotype of human papillomavirus (HPV) 31, 51, 52, 33/58, 35/39/68, and 56/59/66. Standard 16, 18, and 45 versions were announced by Becton, Dickinson, and Company (BD).
  • In June 2020, Illumina received the FDA Emergency Use Authorization for “COVIDSeq,” a Sequencing-Based COVID-19 Diagnostic Test. This test includes 98 amplicons to target the entire SARS-CoV-2 genome, creating efficient detection and high sensitivity.
  • In March 2020, amplicon-based NGS panel, CleanPlex SARS-CoV-2 Panel for sequencing whole genome of SARS-COV-2 on both Illumina and MGI Tech Sequencing Platforms, developed by Paragon Genomics team. These panels were designed to get complete viral genomes even from samples with very low viral content.
  • In November 2019, the US Food and Drug Administration approved the sale of a test to detect type 1 drug resistance mutations in the human immunodeficiency virus (HIV) using NGS technology. The Sentosa SQ HIV Genotyping Assay was the first HIV drug resistance assay using NGS technology and was approved by the FDA for sale in the United States.

Such developments by market players are driving the genotyping market. 

Product and Services Insights

Based on the product and services, the genotyping market is segmented into instruments, reagents and kits, bioinformatics, and genotyping services. The reagent and kits segment will hold the largest market share in 2022. Moreover, the same segment is anticipated to register the highest CAGR during the forecast period due to the high demand by the consumers and the rising initiatives of market players in the launch and product expansion.

Genotyping Market, by Product and Services – 2022 and 2028

  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
  • Request discounts available for Start-Ups & Universities

Technology Insights

Based on Technology, the genotyping market is segmented into Microarrays, Capillary Electrophoresis, Sequencing, Matrix-Assisted Laser Desorption/Ionization-Time of Flight (Maldi-ToF), Mass Spectrometry, Polymerase Chain Reaction (PCR), and Others. In 2022, the polymerase chain reaction (PCR) segment will likely hold the market's largest share. Further, the Sequencing segment is expected to witness growth in its demand at the fastest CAGR from 2022 to 2028, owing to its higher specificity and capacity to detect the low expression and differentially expressed genes.

Application Insights

Based on application, the genotyping market is segmented into pharmacogenomics, diagnostics and personalized medicine, animal genetics, agricultural biotechnology, and others. In 2022, the diagnostics and personalized medicine segment is likely to hold the largest share of the market. Moreover, the Pharmacogenomics segment is also expected to witness growth in its demand at the fastest CAGR from 2022 to 2028, owing to more comprehensive, time- and cost-effective methods available and similar launches across the globe.

End User Insights

Based on end-user, the genotyping market is segmented into pharmaceutical and biopharmaceutical companies, diagnostic and research laboratories, academic institutes, and others. In 2022, the diagnostic and research laboratories segment is likely to hold the largest share of the market. Moreover, the Pharmaceutical and Biopharmaceutical Companies segment is expected to witness growth in its demand at the fastest CAGR from 2022 to 2028, owing to the rise in the number of products by Pharmaceutical and Biopharmaceutical Companies across the globe.

Organic developments such as product launches are highly adopted strategies by the global genotyping market players. A few of the recent key market developments are listed below:

In May 2022, Qiagen launched the QIAstat-Dx Rise syndromic testing platform that provides automated, comprehensive pathogen testing for higher-demand medical institutions. QIAstat-Dx Rise and its test cartridges are a closed system for hands-off sample preparation and processing. With a random-access capacity of up to 18 different tests, it can provide diagnostic results for up to 56 tests in an eight-hour shift and 160 tests per day by using eight analytical modules. Building on the existing QIAstat-Dx Analyzer with up to four analytical modules, QIAstat-Dx Rise is a flexible new option for increased testing capacity.

In Jan 2021, Thermo Fisher Scientific Inc., the world leader in serving science, is empowering scientists to drive groundbreaking discoveries by introducing new-generation mass spectrometry instruments, workflows, and software.

Genotyping – Market Segmentation

The global genotyping market is segmented into product and service, technology, application, end user, and geography. Based on Product and Service, the market is segmented into Instruments, Reagents and Kits, Bioinformatics, and Genotyping Services. Based on the Technology, the market is segmented into Microarrays, Capillary Electrophoresis, Sequencing, Polymerase Chain Reaction (PCR), and Matrix-Assisted Laser Desorption/Ionization-Time of Flight (Maldi-Tof) Mass Spectrometry, and Others. Based on Application, the market is differentiated into Pharmacogenomics, Diagnostics and Personalized Medicine, Animal Genetics, Agricultural Biotechnology, and Others. Based on End-User, the market is segmented into Pharmaceutical and Biopharmaceutical Companies, Diagnostic and Research Laboratories, Academic Institutes, and Others. By geography, the market is segmented into North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America.  

Company Profiles

  • F. Hoffmann-La Roche Ltd.
  • Integrated DNA Technologies, Inc.
  • QIAGEN
  • MERCK KGaA
  • Eurofins Genomics
  • Thermo Fisher Scientific Inc
  • BioTek Instruments, Inc.
  • Xcelris Genomics
  • TrimGen Corporation
  • Illumina, Inc.
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

Product and Service, Technology, Application, End-User and Geography

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

Argentina, Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Mexico, Saudi Arabia, South Africa, South Korea, Spain, United Arab Emirates, United Kingdom, United States

Frequently Asked Questions


Which technology type held the largest share in the genotyping market?

In 2021, the polymerase chain reaction (PCR) held the largest share of the market by technology.

Who are the key players in the genotyping market?

The genotyping market majorly consists of players such as F. Hoffmann-La Roche Ltd., Integrated DNA Technologies, Inc. (Danaher), Qiagen, Merck KGaA, Eurofins Genomics, Thermo Fisher Scientific Inc., BioTek Instruments, Inc., Xcelris Genomics, Trimgen Corporation, and Illumina, Inc.

Which are the top companies that hold the market share in the genotyping market?

F. HOFFMANN LA ROCHE LTD and Illumina, Inc.are the top two companies that hold huge market shares in the genotyping market.

Which product and services led the genotyping market?

In 2021, the reagents and kits segment accounted for the largest share of the market; it is further expected to continue its dominance over the forecast period. The major driving factor for the growth of the reagents and kits segment is the a wide range of genotyping kits is available from several major companies and these products make it easy to observe genetic variation in people, animals, organisms, and individual genes. Moreover, the various companies offer reagents and kits that are widely accepted by consumers is one of the significant factors in the growth of the reagents and kits segment.

What are the driving factors for the genotyping market across the globe?

Key factors driving the growth of this market are the use of genotyping in drug development for genetic and rare diseases and technological advancements and rising R&D investments in pharmaceutical and biotechnology expected to drive the market during the forecast period.

What is the market CAGR value of the genotyping market during the forecast period?

The CAGR value of the genotyping market during the forecasted period of 2021 to 2028 is 21.1%.

What is genotyping?

Genotyping is the technique of identifying the DNA sequence, or genotype, at particular locations across an individual's genome. In linkage and association studies, sequence variations can be employed as markers to find the genes responsible for certain characteristics or diseases. Understanding the relationship between genotypes and phenotypes requires knowledge of genotyping. When compared to a reference sequence that comes from the general population or a specific subgroup, an individual genome is recognized as a distinct variant. There are several ways in which a variant sequence might diverge from the reference sequence. Single nucleotide variations (SNV), single nucleotide polymorphisms (SNPs), insertions and deletions (indels), and copy number variation (CNV) are examples of genetic variation.

The List of Companies - Genotyping Market 

  1. F. Hoffmann-La Roche Ltd.
  2. Integrated DNA Technologies, Inc.
  3. QIAGEN
  4. MERCK KGaA
  5. Eurofins Genomics
  6. Thermo Fisher Scientific Inc
  7. BioTek Instruments, Inc.
  8. Xcelris Genomics
  9. TrimGen Corporation
  10. Illumina, Inc.

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • 3.1 Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • 3.2 Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • 3.3 Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • 3.4 Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Trends and growth analysis reports related to Genotyping Market